Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Stimulants01:29

Stimulants

770
Stimulants are substances that enhance neural activity and elevate dopamine levels in the brain, leading to their highly addictive nature. These drugs include cocaine, amphetamines, MDMA, caffeine, and nicotine, each with distinct mechanisms of action and varied health implications.
Cocaine can be administered via snorting, injection, or smoking. It primarily functions by blocking the reuptake of dopamine, resulting in a euphoric high characterized by an intense sensation of happiness and...
770
Drugs Acting on Autonomic Ganglia: Stimulants01:23

Drugs Acting on Autonomic Ganglia: Stimulants

2.0K

Ganglionic stimulants activate NM nicotinic receptors in autonomic ganglia, falling into two categories: nicotine mimetics [e.g., lobeline, dimethylpiperazine, tetramethylammonium] and muscarinic receptor agonists [e.g., muscarine, methacholine]. The first category's action is rapid and blocked by nicotinic receptor antagonists, while the second category's action is delayed and blocked by atropine-like agents. Nicotine, an alkaloid, affects the heart rate by stimulating...
2.0K
Clinically Relevant Drug Product Specifications: Methods of Establishment01:29

Clinically Relevant Drug Product Specifications: Methods of Establishment

134
Product specifications define the acceptable quality of a pharmaceutical product by ensuring identity, purity, potency, and strength. These specifications serve as benchmarks during development, manufacturing, and post-approval quality control. Clinically relevant specifications are particularly important because they directly relate to a drug's safety and efficacy in clinical use.Dissolution studies are critical biopharmaceutic tools that link in vitro behavior to in vivo performance. They...
134
2° Amines to N-Nitrosamines: Reaction with NaNO201:20

2° Amines to N-Nitrosamines: Reaction with NaNO2

5.2K
Secondary amines react with nitrous acid to form N-nitrosamines, as depicted in Figure 1. Nitrous acid, a weak and unstable acid, is formed in situ from an aqueous solution of sodium nitrite and strong acids, such as hydrochloric acid or sulfuric acid, in cold conditions. In the presence of an acid, the nitrous acid gets protonated. The subsequent loss of water results in the formation of the electrophile known as nitrosonium ion.
5.2K
Cholinergic Receptors: Nicotinic01:15

Cholinergic Receptors: Nicotinic

5.1K
Nicotinic receptors are ligand-gated ion channels that are activated by acetylcholine and nicotine. Upon activation, they cause a rapid increase in the permeability of cells to K+, Na+, and Ca2+, followed by depolarization and excitation. They are in the autonomic ganglia, skeletal neuromuscular junction, CNS, and adrenal medulla.
There are two types of nicotinic receptors: neuromuscular (NM/NM/N1) and neuronal (NN/NN/N2). The two families differ based on their location and selectivity to...
5.1K
Predicting Products: SN1 vs. SN202:27

Predicting Products: SN1 vs. SN2

15.7K
Nucleophilic substitution reactions of alkyl halides can proceed via an SN1 or an SN2 mechanism. While in SN2 reactions, the nucleophile attacks the substrate simultaneously as the leaving group departs, in SN1 reactions, the substrate first dissociates to give the carbocation intermediate. Various factors such as the structure of the substrate, the strength of the nucleophile, and the nature of the solvent promote one mechanism over the other.
With increased substitution on the alkyl halide,...
15.7K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The emerging role of oral nicotine pouches in tobacco harm reduction.

Internal and emergency medicine·2025
Same author

Two decades of global tobacco control: time for a rethink.

Internal and emergency medicine·2025
Same author

Health effects of e-cigarettes, heated tobacco, and oral nicotine products.

Internal and emergency medicine·2025
Same author

Inaccurate and misleading meta-analysis of E-cigarettes and population-based diseases.

Internal and emergency medicine·2025
Same author

The many dangers of e-cigarette misinformation.

Oral surgery, oral medicine, oral pathology and oral radiology·2025
Same author

Joint smoking-vaping prevalence rates among American youth and young adults 2011-2022.

Harm reduction journal·2024

Related Experiment Video

Updated: Dec 26, 2025

Comparing the Effects of Electronic Cigarette Vapor and Cigarette Smoke in a Novel In Vivo Exposure System
10:44

Comparing the Effects of Electronic Cigarette Vapor and Cigarette Smoke in a Novel In Vivo Exposure System

Published on: May 24, 2017

11.9K

Initial Information on a Novel Nicotine Product.

Nantaporn Plurphanswat1, John R Hughes2, Karl Fagerström3

  • 1James Graham Brown Cancer Center, University of Louisville, Louisville, Kentucky.

The American Journal on Addictions
|March 17, 2020
PubMed
Summary
This summary is machine-generated.

New nicotine pouches, ZYN, show significant appeal among current and former smokeless tobacco users. These users are more interested in ZYN, citing reduced harm and ease of use as primary reasons.

More Related Videos

Generation of Electronic Cigarette Aerosol by a Third-Generation Machine-Vaping Device: Application to Toxicological Studies
08:39

Generation of Electronic Cigarette Aerosol by a Third-Generation Machine-Vaping Device: Application to Toxicological Studies

Published on: August 25, 2018

26.2K
A Microcontroller Operated Device for the Generation of Liquid Extracts from Conventional Cigarette Smoke and Electronic Cigarette Aerosol
09:30

A Microcontroller Operated Device for the Generation of Liquid Extracts from Conventional Cigarette Smoke and Electronic Cigarette Aerosol

Published on: January 18, 2018

8.7K

Related Experiment Videos

Last Updated: Dec 26, 2025

Comparing the Effects of Electronic Cigarette Vapor and Cigarette Smoke in a Novel In Vivo Exposure System
10:44

Comparing the Effects of Electronic Cigarette Vapor and Cigarette Smoke in a Novel In Vivo Exposure System

Published on: May 24, 2017

11.9K
Generation of Electronic Cigarette Aerosol by a Third-Generation Machine-Vaping Device: Application to Toxicological Studies
08:39

Generation of Electronic Cigarette Aerosol by a Third-Generation Machine-Vaping Device: Application to Toxicological Studies

Published on: August 25, 2018

26.2K
A Microcontroller Operated Device for the Generation of Liquid Extracts from Conventional Cigarette Smoke and Electronic Cigarette Aerosol
09:30

A Microcontroller Operated Device for the Generation of Liquid Extracts from Conventional Cigarette Smoke and Electronic Cigarette Aerosol

Published on: January 18, 2018

8.7K

Area of Science:

  • Consumer product research
  • Tobacco product analysis
  • Nicotine product perception

Background:

  • First study assessing appeal and interest in ZYN, a new consumer tobacco product.
  • Describes ZYN users, usage patterns, and motivations.
  • Focuses on adult consumers' perceptions of novel tobacco alternatives.

Purpose of the Study:

  • To evaluate the appeal and interest in ZYN among adult consumers.
  • To characterize ZYN users, including patterns and reasons for use.
  • To understand the potential of ZYN as a reduced-risk product or cessation aid.

Main Methods:

  • Utilized two datasets: a ZYN-naive consumer panel (n=5179) and existing ZYN users (n=1266).
  • Employed descriptive, cross-sectional analyses and logistic regression.
  • Assessed perceptions, purchase likelihood, and user characteristics.

Main Results:

  • Majority of current smokeless tobacco (ST) users found ZYN moderately to extremely appealing.
  • Former tobacco users showed higher likelihood to purchase ZYN compared to other groups.
  • Primary reasons for use: perceived lower health risk and ease of use; 43% of users were former tobacco users.

Conclusions:

  • Current and former tobacco users perceive ZYN as a potentially reduced-risk nicotine product.
  • ZYN's appeal to ST users suggests potential utility as a smoking/tobacco cessation aid.
  • Non-tobacco users showed minimal interest in ZYN.